ePharmacy Market (2026 - 2033)

ePharmacy Market Summary

The global ePharmacy market size was valued at USD 120.7 billion in 2025 and is projected to grow from USD 147.8 billion in 2026 to USD 513.4 billion in 2033, at a CAGR of 19.5% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 38.0% in 2025. Rising penetration of the internet across the globe, improving digitalization of healthcare services, and an increasing number of tech-savvy consumers are the key factors boosting the market growth.

The boom in the healthcare sector, coupled with high operational costs, has created the need to cut operational costs with the implementation of ePharmacy solutions. The increasing prevalence of chronic conditions is leading to a rise in the demand for various healthcare products, including drugs. This signifies the increasing penetration of online modes of drug procurement across the globe.

The growth and development of e-commerce has a significant impact on the ePharmacy market. While medical stores are classified as vital services, online pharmacies have emerged as one of the largest beneficiaries of the pandemic-induced lockdown, as individuals preferred to buy medicines online to avoid the risk of disease spreading.

 In January 2026, online pharmacy Pharmacy2U reported a rise of 64.5% in the NHS prescriptions that were dispensed during the financial year to April 2025, compared with the previous year. The market will continue to grow, mainly driven by consumer adoption of these platforms for the convenience, affordability, and accessibility. Increasing digitization and the benefits associated with the adoption of ePharmacy over traditional pharmacies are anticipated to drive market growth in the coming years.

Market Dynamics

Analyst Perspective

The ePharmacy market is expected to grow significantly over the coming years, driven by rising internet penetration and increasing adoption of digital healthcare services. An aging population and the growing prevalence of chronic diseases are further boosting demand. Consumers are increasingly choosing ePharmacies for doorstep medicine delivery, cost savings, and improved accessibility. Market players are enhancing their offerings with telehealth integration, AI-powered prescription management, and personalized patient engagement. These innovations, along with supportive regulatory developments, are expected to drive sustained market growth globally.

Drug Type Insights

The over-the-counter drug segment accounted for the largest market share of over 60.0% in 2025. OTC (over-the-counter) drugs make up the largest share of e-pharmacy sales due to their ease of access, convenience for consumers, and increased self-medication by consumers. Consumers can buy OTC products without the need for a doctor's prescription; therefore, they can quickly order medicine for common ailments (such as colds, headaches, allergies, stomach problems, and/or mild pain). For instance, in August 2025, Zepto launched Zepto Pharmacy in select Indian cities, offering ultra-fast medicine delivery services. The launch underscores the rising demand for convenient access to OTC medicines and wellness products, while demonstrating how e-pharmacy providers are leveraging rapid delivery models to strengthen customer engagement and drive market growth.

Prescription drugs are expected to register significant growth during the forecast period. The category has become the most rapidly expanding category in the e-pharmacy market with the rise in the number of individuals living with chronic disease, the need for sustained management of medications over long periods of time, and increased usage of telehealth. Patients with a need for frequent treatment for conditions like diabetes, heart disease, hypertension, and obesity can now easily refill their prescriptions through digital pharmacies without the need of frequently visit hospitals. A key supporting development comes from the Ministry of Health and Family Welfare, Government of India, which is building a National Digital Health Ecosystem. This initiative focuses on creating interoperable electronic health records and improving digital access to healthcare services. By enabling the use of e-prescriptions and better connectivity between healthcare providers, it is helping strengthen digital healthcare delivery and support wider adoption of online medicine distribution across the country.

Regional Insights

North America accounted for the largest market share of over 38.0% in 2025. Rising adoption of e-commerce, growing geriatric population, increasing online sales, developed healthcare infrastructure, and positive attitude toward the adoption of new technologies are some of the major factors contributing to the regional market growth. Moreover, nearly 80% of the U.S. population is connected to ePharmacies, and the trend is shifting toward the direct-to-patient model.

The digital world has opened the door to consumer-friendly online experiences and other advanced services, further propelling overall market growth in North America. For instance, in February 2026, Amazon's (AMZN.O) pharmacy announced plans to expand its same-day delivery prescription services by the end of this year to about 4,500 cities and towns in the U.S., integrating around 2,000 new communities into its existing network. The expansion will offer fast and reliable medication delivery to more customers nationwide, including those in newly served states such as Idaho and Massachusetts.

Asia Pacific ePharmacy Market Trends

Asia Pacific is anticipated to register the fastest CAGR during the forecast period. Emerging economies, such as China and India, possess high growth potential owing to the large population bases and increasing government initiatives to support the adoption of digital technologies. With an increase in the number of strategic initiatives by various public and private organizations, the market in the Asia Pacific is anticipated to grow at a faster pace in the coming years. For instance, in August 2025, Truemeds, an Indian e-pharmacy offering products focused on chronic care, raised USD 85 million in a Series C round to extend its presence and reach across India’s non-metro markets.

Key ePharmacy Company Insights

Key players implement various marketing strategies to gain a competitive edge and increase their share. In addition, the companies also implement strategies, such as mergers, acquisitions, and partnerships, to increase their market share.

Key ePharmacy Companies:

The following key companies have been profiled for this study on the ePharmacy market

• The Kroger Co.

• Walgreen Co.

• Giant Eagle, Inc.

• Walmart, Inc.

• Express Scripts Holding Company

• CVS Health

• Optum Rx, Inc.

• Rowlands Pharmacy

• DocMorris (Zur Rose Group AG)

• Cigna Corporation (Express Scripts Holdings)

• Amazon.com Inc.

• Axelia Solutions (Pharmeasy)

• Apex Healthcare Berhad (Apex Pharmacy)

• Apollo Pharmacy

• Netmeds

Recent Developments

• In February 2026, Hims & Hers Health announced its acquisition of Australian digital health company Eucalyptus in a deal valued at around USD 1.15 billion. The acquisition is part of Hims & Hers' strategy to expand its international presence and strengthen its personalized healthcare offerings. By entering new global markets through Eucalyptus, the company aims to accelerate growth and enhance access to digital health services for a broader customer base.

• In May 2026, CEPD acquired the Atida Group from OLP Intermediate S.A., enhancing its presence in the European pharmacy retail and digital healthcare market. The acquisition is expected to support the growth strategy of the Corporation of European Pharmaceutical Distributors (CEPD) by expanding its healthcare e-commerce and pharmacy network operations.

ePharmacy Market Report Scope

Global ePharmacy Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ePharmacy market report based on drug type, and region:

• Drug Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Prescription drug

  • Over-the-counter drug (OTC)

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • Spain

    • Italy

    • France

    • Russia

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Singapore

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait